The low-density lipoprotein receptor promotes infection of multiple encephalitic alphaviruses.
Hongming MaLucas J AdamsSaravanan RajuAlan SariolNatasha M KafaiHana JanovaWilliam B KlimstraDaved H FremontMichael S. DiamondPublished in: Nature communications (2024)
Members of the low-density lipoprotein receptor (LDLR) family, including LDLRAD3, VLDLR, and ApoER2, were recently described as entry factors for different alphaviruses. However, based on studies with gene edited cells and knockout mice, blockade or abrogation of these receptors does not fully inhibit alphavirus infection, indicating the existence of additional uncharacterized entry factors. Here, we perform a CRISPR-Cas9 genome-wide loss-of-function screen in mouse neuronal cells with a chimeric alphavirus expressing the Eastern equine encephalitis virus (EEEV) structural proteins and identify LDLR as a candidate receptor. Expression of LDLR on the surface of neuronal or non-neuronal cells facilitates binding and infection of EEEV, Western equine encephalitis virus, and Semliki Forest virus. Domain mapping and binding studies reveal a low-affinity interaction with LA domain 3 (LA3) that can be enhanced by concatenation of LA3 repeats. Soluble decoy proteins with multiple LA3 repeats inhibit EEEV infection in cell culture and in mice. Our results establish LDLR as a low-affinity receptor for multiple alphaviruses and highlight a possible path for developing inhibitors that could mitigate infection and disease.
Keyphrases
- low density lipoprotein
- induced apoptosis
- genome wide
- crispr cas
- cell cycle arrest
- south africa
- stem cells
- genome editing
- cell death
- type diabetes
- high resolution
- copy number
- signaling pathway
- mesenchymal stem cells
- bone marrow
- gene expression
- cell therapy
- high throughput
- cerebral ischemia
- mass spectrometry
- wild type
- insulin resistance